Literature DB >> 10712387

Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells.

S L Harley1, J Sturge, J T Powell.   

Abstract

It has been reported that fibrinogen may act as a bridging ligand, binding to intercellular adhesion molecule-1 (ICAM-1) on human umbilical vein endothelial cells and to Mac-1 on THP-1 cells (a monocytic cell line) to increase adhesion. In this study, we investigated whether fibrinogen altered the expression of ICAM-1 and, thus, increased the adhesion of THP-1 cells to cultured human saphenous vein endothelial cells (HSVECs). Incubation of HSVECs with 0.3 to 4 micromol/L fibrinogen caused a time- and concentration-dependent increase in ICAM-1, as determined by ELISA. The 4- to 5-fold increase in ICAM-1 protein concentration in HSVECs stimulated by 4 micromol/L fibrinogen for 6 hours was concomitant with a 4- to 5-fold increase in ICAM-1 mRNA. This fibrinogen-stimulated ICAM-1 upregulation was associated with a 2-fold increase in THP-1 cell adhesion to HSVECs. The fibrinogen-derived peptide Bbeta15-42 bound to HSVECs (K(d) 0.18 micromol/L). Preincubation of HSVECs with Bbeta15-42, a neutralizing antibody to urokinase plasminogen activator (uPA), or the F(ab)(1) fragment of a monoclonal antibody to vascular endothelial cadherin significantly attenuated the increase in ICAM-1 stimulated by fibrinogen. Capillary electrophoretic analysis indicated that anti-uPA prevented the release of any fibrinopeptide B (Bbeta1-14) in cultures of HSVECs incubated with 4 micromol/L fibrinogen for 6 hours. Moreover, incubation of HSVECs with either fibrin monomer (1 micromol/L) or monoclonal antibodies to vascular endothelial cadherin (25 microg/mL) increased ICAM-1 protein concentration 3- to 4-fold. These findings indicate that cleavage of fibrinopeptide B from fibrinogen by endothelial uPA permits the exposed Bbeta15-42 sequence of fibrinogen to bind to vascular endothelial cadherin on HSVECs and to upregulate the expression of ICAM-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712387     DOI: 10.1161/01.atv.20.3.652

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  21 in total

Review 1.  Novel aspects of fibrin(ogen) fragments during inflammation.

Authors:  Carla Jennewein; Nguyen Tran; Patrick Paulus; Peter Ellinghaus; Johannes Andreas Eble; Kai Zacharowski
Journal:  Mol Med       Date:  2011-01-04       Impact factor: 6.354

2.  Elevated Levels of Serum Fibrin and Fibrinogen Degradation Products Are Independent Predictors of Larger Coronary Plaques and Greater Plaque Necrotic Core.

Authors:  Michel T Corban; Olivia Y Hung; Girum Mekonnen; Parham Eshtehardi; Danny J Eapen; Emad Rasoul-Arzrumly; Hatem Al Kassem; Pankaj Manocha; Yi-An Ko; Laurence S Sperling; Arshed A Quyyumi; Habib Samady
Journal:  Circ J       Date:  2016-02-25       Impact factor: 2.993

Review 3.  Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction.

Authors:  Kai Zacharowski; Paula Zacharowski; Sonja Reingruber; Peter Petzelbauer
Journal:  J Mol Med (Berl)       Date:  2006-05-06       Impact factor: 4.599

4.  Fibrinogen-induced increased pial venular permeability in mice.

Authors:  Nino Muradashvili; Natia Qipshidze; Charu Munjal; Srikanth Givvimani; Richard L Benton; Andrew M Roberts; Suresh C Tyagi; David Lominadze
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-12       Impact factor: 6.200

5.  Endocarditis-associated oral streptococci promote rapid differentiation of monocytes into mature dendritic cells.

Authors:  Chin-Lo Hahn; Harvey A Schenkein; John G Tew
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study.

Authors:  Eirini V Theodoraki; Tiit Nikopensius; Julia Suhorutsenko; Vassileios Peppes; Panagiota Fili; Genovefa Kolovou; Vassileios Papamikos; Dimitrios Richter; Nikolaos Zakopoulos; Kaarel Krjutskov; Andres Metspalu; George V Dedoussis
Journal:  BMC Med Genet       Date:  2010-02-18       Impact factor: 2.103

7.  Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts.

Authors:  Thomas A Abbruzzese; Joaquim Havens; Michael Belkin; Magruder C Donaldson; Anthony D Whittemore; James K Liao; Michael S Conte
Journal:  J Vasc Surg       Date:  2004-06       Impact factor: 4.268

Review 8.  Role of fibrinogen in cerebrovascular dysfunction after traumatic brain injury.

Authors:  Nino Muradashvili; David Lominadze
Journal:  Brain Inj       Date:  2013-09-24       Impact factor: 2.311

9.  A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries.

Authors:  Antonio J Lepedda; Antonio Cigliano; Gian Mario Cherchi; Rita Spirito; Marco Maggioni; Franco Carta; Franco Turrini; Celina Edelstein; Angelo M Scanu; Marilena Formato
Journal:  Atherosclerosis       Date:  2008-07-12       Impact factor: 5.162

Review 10.  Fibrinogen and Neuroinflammation During Traumatic Brain Injury.

Authors:  Nurul Sulimai; David Lominadze
Journal:  Mol Neurobiol       Date:  2020-08-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.